Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection.
Título
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection.
Autor
Mattia Trunfio, Elena Salvador, Daniela Cabodi, Letizia Marinaro, Chiara Alcantarini, Alberto Gaviraghi, Alice Trentalange, Filippo Lipani, Savino Sciascia, Dario Roccatello, Stefano Bonora, Giovanni Di Perri, Andrea Calcagno
Fecha
2020
Materia
covid-19, SARS-CoV-2, Clinical Outcome, Activated factor X, Heparin, low molecular weight heparin, and related compounds
Identificador
10.1016/j.thromres.2020.09.039
Fuente
Thrombosis research
Archivos
Colección
Citación
Mattia Trunfio, Elena Salvador, Daniela Cabodi, Letizia Marinaro, Chiara Alcantarini, Alberto Gaviraghi, Alice Trentalange, Filippo Lipani, Savino Sciascia, Dario Roccatello, Stefano Bonora, Giovanni Di Perri, Andrea Calcagno, “Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection.,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/5387.
Position: 12054 (23 views)